Genetic and biochemical properties of streptococcal NAD-glycohydrolase inhibitor

被引:20
作者
Kimoto, H
Fujii, Y
Hirano, S
Yokota, Y
Taketo, A
机构
[1] Univ Fukui, Fac Med, Dept Mol Genet, Fukui 9101193, Japan
[2] Univ Fukui, Fac Med, Dept Mol Biol & Chem, Fukui 9101193, Japan
[3] Univ Fukui, Fac Med, Dept Pediat, Fukui 9101193, Japan
[4] Fukui Univ Technol, Dept Environm & Biotechnol Frontier Engn, Fukui 9108505, Japan
关键词
D O I
10.1074/jbc.M506879200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gene encoding streptolysin O (slo), a cytolysin of hemolytic streptococci, is transcribed polycistronically from the promoter of the preceding NAD-glycohydrolase (NADase) gene (nga). Between nga and slo, a putative open reading frame (orf1) is located whose function has been totally unknown. Present investigation demonstrated that the orf1 encodes a protein designated as streptococcal NADase inhibitor (SNI). From its nucleotide sequence, SNI was inferred to comprise 161 amino acid residues and the deduced molecular weight was 18,800. This protein was detectable only within cells. Coexpression of SNI was essential for production of streptococcal NADase, and NADase precursor existed as an inactive complex with SNI, in recombinant Escherichia coli. Monomeric NADase and SNI rapidly formed in vitro a stable heterodimer complex in the ratio 1:1, resulting in complete suppression of the hydrolase activity. Unlike other bacterial NADase inhibitors, SNI was thermostable. This protein, coexpressed and complexed with NADase, may protect the producer cocci from exhaustion of NAD.
引用
收藏
页码:9181 / 9189
页数:9
相关论文
共 39 条
[1]   STREPTOCOCCAL TOXINS (STREPTOLYSIN-O, STREPTOLYSIN-S, ERYTHROGENIC TOXIN) [J].
ALOUF, JE .
PHARMACOLOGY & THERAPEUTICS, 1980, 11 (03) :661-717
[2]  
Alouf JE, 2000, INT J MED MICROBIOL, V290, P351
[3]   Progress toward characterization of the group a Streptococcus metagenome:: Complete genome sequence of a macrolide-resistant serotype M6 strain [J].
Banks, DJ ;
Porcella, SF ;
Barbian, KD ;
Beres, SB ;
Philips, LE ;
Voyich, JM ;
DeLeo, FR ;
Martin, JM ;
Somerville, GA ;
Musser, JM .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (04) :727-738
[4]   Genome sequence of a serotype M3 strain of group A Streptococcus:: Phage-encoded toxins, the high-virulence phenotype, and clone emergence [J].
Beres, SB ;
Sylva, GL ;
Barbian, KD ;
Lei, BF ;
Hoff, JS ;
Mammarella, ND ;
Liu, MY ;
Smoot, JC ;
Porcella, SF ;
Parkins, LD ;
Campbell, DS ;
Smith, TM ;
McCormick, JK ;
Leung, DYM ;
Schlievert, PM ;
Musser, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :10078-10083
[5]  
BHAKDI S, 1985, INFECT IMMUN, V47, P52
[6]   Staphylococcal alpha-toxin, streptolysin-O, and Escherichia coli hemolysin: Prototypes of pore-forming bacterial cytolysins [J].
Bhakdi, S ;
Bayley, H ;
Valeva, A ;
Walev, I ;
Walker, B ;
Weller, U ;
Kehoe, M ;
Palmer, M .
ARCHIVES OF MICROBIOLOGY, 1996, 165 (02) :73-79
[7]   Thiol-activated cytolysins: structure, function and role in pathogenesis [J].
Billington, SJ ;
Jost, BH ;
Songer, JG .
FEMS MICROBIOLOGY LETTERS, 2000, 182 (02) :197-205
[8]   Type III secretion systems: what is the translocator and what is translocated? [J].
Blocker, A ;
Holden, D ;
Cornelis, G .
CELLULAR MICROBIOLOGY, 2000, 2 (05) :387-390
[9]   Port of entry -: the type III secretion translocon [J].
Büttner, D ;
Bonas, U .
TRENDS IN MICROBIOLOGY, 2002, 10 (04) :186-192
[10]   SELECTIVE INHIBITION BY PREPARATIONS OF STREPTOCOCCAL FILTRATES OF THE OXIDATIVE METABOLISM OF MITOCHONDRIA PROCURED FROM RABBIT MYOCARDIUM [J].
CARLSON, AS ;
KELLNER, A ;
BERNHEIMER, AW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1956, 104 (04) :577-587